Mitochondrial DNA Deletion and Cancer in Turkish Patients
Author Information
Author(s): Aral Cenk, Akkiprik Mustafa, Kaya Handan, Ataizi-Çelikel Çigdem, Çaglayan Sinan, Özisik Gökhan, Baloglu Hüseyin, Özer Ayse
Primary Institution: Namik Kemal University, Marmara University, Gulhane Military School of Medicine
Hypothesis
Is the mitochondrial DNA common deletion associated with thyroid, breast, and colorectal tumors in Turkish patients?
Conclusion
The mitochondrial common deletion was very rare in the study group and did not appear to be related to cancer.
Supporting Evidence
- The mitochondrial common deletion was detected in only six thyroid cancer samples.
- All samples amplified wild-type mtDNA, but the common deletion was rare.
- Previous studies showed inconsistent results regarding the association of the common deletion with various cancers.
Takeaway
The study looked for a specific DNA change in cancer patients but found it was very rare and not linked to the cancers studied.
Methodology
Two PCR-based methods were used to detect the mitochondrial common deletion in tumor and adjacent healthy tissues.
Limitations
The relatively small number of patients was a main limitation, suggesting further studies with larger cohorts are needed.
Participant Demographics
The study included 100 cancer patients with breast, colorectal, and thyroid tumors, with varying ages and genders.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website